Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 From NASS: New Bone Graft Substitute for Orthofix - Orthopedic Design & Technology

From NASS: New Bone Graft Substitute for Orthofix

Execs say company will expand its protfolio of biologic products.

Orthofix International recently released its Collage Osteoconductive Scaffold, a new bone graft substitute or use in spine and orthopedic indications.

The rollout came during the North American Spine Society (NASS) meeting annual meeting held in Chicago, Ill.

According to the company the new synthetic platform is based on “highly-purified biocompatible materials of ss-TCP and type-1 collagen.”

Michael Finegan, president of the firm’s Biologics unit said the company would begin to focus on broadening its portfolio of biologic products.

“The synthetic segment of the market is large, attractive, and presents a perfect complement to our existing biologic portfolio,” he said.

The U.S. market for synthetic bone graft substitutes is estimated to include more than 320,000 procedures and is valued at approximately $360 million annually, according to a recent iData Research report.

Orthofix International is based outside Dallas, Texas.

Add us as a preferred source on Google

Get the latest Orthopedic Design & Technology news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Orthopedic Design & Technology Newsletters